28APR201122294087
This document comprises a Prospectus relating to Glencore International plc (the ‘‘Company’’) and has been prepared in accordance with
the Prospectus Rules of the Financial Services Authority (the ‘‘FSA’’) made under Section 73A of the Financial Services and Markets Act
2000 (as amended) (the ‘‘FSMA’’), has been filed with the FSA and has been made available to the public as required by the Prospectus
Rules.
Application has been made to the FSA for all of the Ordinary Shares, issued and to be issued in connection with the Global Offer, to be
admitted to the premium listing segment of the Official List of the FSA (the ‘‘Official List’’) and to the London Stock Exchange plc (the
‘‘London Stock Exchange’’) and for such Ordinary Shares to be admitted to trading on the London Stock Exchange’s main market for listed
securities (together ‘‘UK Admission’’). UK Admission constitutes admission to trading on a regulated market. Application has also been
made to the Listing Committee of the Hong Kong Stock Exchange for listing of, and permission to deal in, all of the Ordinary Shares on the
Main Board of the Hong Kong Stock Exchange (‘‘HK Admission’’). In the Global Offer, up to 988,973,234 new Ordinary Shares are being
made available by the Company and up to 261,026,766 Ordinary Shares are being made available by the Selling Shareholder. Conditional
dealings in the Ordinary Shares on a ‘‘when issued’’ basis are expected to commence on the London Stock Exchange on 19 May 2011. It is
expected that UK Admission will become effective, and that unconditional dealings will commence in the Ordinary Shares on the London
Stock Exchange, at 8.00 a.m. (London time) on 24 May 2011.
All dealings in the Ordinary Shares prior to the commencement of
unconditional dealings on the London Stock Exchange will be of no effect if UK Admission does not take place and such dealings will be at the
sole risk of the parties concerned. It is expected that HK Admission will become effective on 25 May 2011 and that unconditional dealings will
commence in the Ordinary Shares on the Main Board of the Hong Kong Stock Exchange at 9.00 a.m. (Hong Kong time) on 25 May 2011. The
new Ordinary Shares issued by the Company will rank
pari passu
in all respects with the existing Ordinary Shares.
The Company and its Directors (whose names appear on page 30 of this Prospectus) accept responsibility for the information contained in
this Prospectus. To the best of the knowledge and belief of the Company and the Directors (who have taken all reasonable care to ensure
that such is the case), the information contained in this Prospectus is in accordance with the facts and contains no omission likely to affect
the import of such information.
Prospective investors should read the whole of this Prospectus, including the discussions of certain risk and other factors that should be
considered in connection with an investment in the Ordinary Shares, see ‘‘Risk Factors’’.
GLENCORE INTERNATIONAL PLC
(incorporated in Jersey under the Companies (Jersey) Law 1991 with registered number 107710)
Prospectus
Global Offer of up to 1,250,000,000 Ordinary Shares at a price
expected to be between 480 pence and 580 pence per Ordinary Share
Admission to the Premium Listing segment of the
Official List and to trading on the London Stock Exchange
and Secondary Listing on the Hong Kong Stock Exchange
Citi
Credit Suisse
Morgan Stanley
Joint Global Co-ordinator
Joint Global Co-ordinator
Joint Global Co-ordinator
Joint Bookrunner
Joint Bookrunner
Joint Bookrunner
Joint Sponsor
Joint Sponsor
Joint Bookrunners
BofA Merrill Lynch
BNP PARIBAS
Co-Bookrunners
Barclays Capital
Soci´
et´
e G´
en´
erale
UBS Investment Bank
Joint Lead Managers
Cr´
edit Agricole CIB
HSBC
ING
Co-Lead Managers
ABN AMRO
Banco Santander
DBS
Liberum Capital
Natixis
The Royal Bank
of Scotland
Co-Managers
BOC International
COMMERZBANK
Mizuho International plc
Rabobank
Sberbank
Standard
International
of Russia
Chartered
Ordinary Share capital immediately following Admission
(assuming the Offer Price is set at the mid-point of the Offer Price Range and no exercise of the Over-Allotment Option)
Authorised
Issued and fully paid
Number
Amount
Number
Amount
50,000,000,000
U.S.$500,000,000
6,893,292,886
US$68,932,928.86
Ordinary Shares of U.S.$0.01 each